Cargando…

Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial

BACKGROUND: Since the introduction of antiretroviral therapy (ART), the incidence of HIV-associated dementia has drastically fallen. Despite using ART, people living with HIV continue to experience less severe but limiting forms of HIV-associated neurocognitive disorder (HAND). People living with HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Nweke, Martins, Mshunqane, Nombeko, Govender, Nalini, Akinpelu, Aderonke, Ogunniyi, Adesola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844984/
https://www.ncbi.nlm.nih.gov/pubmed/35099405
http://dx.doi.org/10.2196/29230
_version_ 1784651582638391296
author Nweke, Martins
Mshunqane, Nombeko
Govender, Nalini
Akinpelu, Aderonke
Ogunniyi, Adesola
author_facet Nweke, Martins
Mshunqane, Nombeko
Govender, Nalini
Akinpelu, Aderonke
Ogunniyi, Adesola
author_sort Nweke, Martins
collection PubMed
description BACKGROUND: Since the introduction of antiretroviral therapy (ART), the incidence of HIV-associated dementia has drastically fallen. Despite using ART, people living with HIV continue to experience less severe but limiting forms of HIV-associated neurocognitive disorder (HAND). People living with HIV who are on ART and experiencing symptoms of HAND may benefit from aerobic exercise. OBJECTIVE: This protocol describes a randomized controlled trial designed to determine the effects of a 12-week aerobic exercise program on HAND in Southeastern Nigeria. METHODS: At least 68 patients diagnosed with HAND will be randomly placed into either an aerobic exercise group or control group. Patients in the aerobic exercise group will perform a moderate intensity workout on a stationary bicycle ergometer, 3 times a week for 12 weeks. We will measure the primary outcomes including neurocognitive performance, prevalence of HAND, viral load, and CD4 count. We will evaluate postexercise neurocognitive performance using reliable neuropsychological tests relevant to people living with HIV, in line with the Frascati criteria. We will assess secondary outcomes such as quality of life, activity limitation, and social participation using the World Health Organization Quality of Life (WHOQOL)-Brief, and the Oxford Participation and Activities questionnaire. We will use exploratory statistics to test the data for normality and homogeneity. We will analyze the effect of the exercise program on HAND using relative risk (RR) and absolute risk reduction (number needed to treat). Analysis of covariance will be run to estimate the effect of exercise on quality of life and activity and participation level. RESULTS: This funded trial was approved by the Institutional Review Board in May 2020. The protocol was approved on June 15, 2020. Enrollment commenced in January 2021 and was completed in May 2021. Over 60% of the participants were recruited at the time of first submission to JMIR Mental Health. Data curation is still ongoing; hence, data analysis is yet to be executed. Study outcomes are expected to be published in March 2022. CONCLUSIONS: This is a protocol for a randomized controlled trial that aims to evaluate the effect of a 12-week aerobic exercise program on HAND in Southeastern Nigeria. TRIAL REGISTRATION: Pan African Clinical Trials Registry PACTR202009483415745; https://tinyurl.com/2p97zpu9 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/29230
format Online
Article
Text
id pubmed-8844984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-88449842022-03-10 Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial Nweke, Martins Mshunqane, Nombeko Govender, Nalini Akinpelu, Aderonke Ogunniyi, Adesola JMIR Res Protoc Protocol BACKGROUND: Since the introduction of antiretroviral therapy (ART), the incidence of HIV-associated dementia has drastically fallen. Despite using ART, people living with HIV continue to experience less severe but limiting forms of HIV-associated neurocognitive disorder (HAND). People living with HIV who are on ART and experiencing symptoms of HAND may benefit from aerobic exercise. OBJECTIVE: This protocol describes a randomized controlled trial designed to determine the effects of a 12-week aerobic exercise program on HAND in Southeastern Nigeria. METHODS: At least 68 patients diagnosed with HAND will be randomly placed into either an aerobic exercise group or control group. Patients in the aerobic exercise group will perform a moderate intensity workout on a stationary bicycle ergometer, 3 times a week for 12 weeks. We will measure the primary outcomes including neurocognitive performance, prevalence of HAND, viral load, and CD4 count. We will evaluate postexercise neurocognitive performance using reliable neuropsychological tests relevant to people living with HIV, in line with the Frascati criteria. We will assess secondary outcomes such as quality of life, activity limitation, and social participation using the World Health Organization Quality of Life (WHOQOL)-Brief, and the Oxford Participation and Activities questionnaire. We will use exploratory statistics to test the data for normality and homogeneity. We will analyze the effect of the exercise program on HAND using relative risk (RR) and absolute risk reduction (number needed to treat). Analysis of covariance will be run to estimate the effect of exercise on quality of life and activity and participation level. RESULTS: This funded trial was approved by the Institutional Review Board in May 2020. The protocol was approved on June 15, 2020. Enrollment commenced in January 2021 and was completed in May 2021. Over 60% of the participants were recruited at the time of first submission to JMIR Mental Health. Data curation is still ongoing; hence, data analysis is yet to be executed. Study outcomes are expected to be published in March 2022. CONCLUSIONS: This is a protocol for a randomized controlled trial that aims to evaluate the effect of a 12-week aerobic exercise program on HAND in Southeastern Nigeria. TRIAL REGISTRATION: Pan African Clinical Trials Registry PACTR202009483415745; https://tinyurl.com/2p97zpu9 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/29230 JMIR Publications 2022-01-31 /pmc/articles/PMC8844984/ /pubmed/35099405 http://dx.doi.org/10.2196/29230 Text en ©Martins Nweke, Nombeko Mshunqane, Nalini Govender, Aderonke Akinpelu, Adesola Ogunniyi. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 31.01.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Nweke, Martins
Mshunqane, Nombeko
Govender, Nalini
Akinpelu, Aderonke
Ogunniyi, Adesola
Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial
title Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial
title_full Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial
title_fullStr Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial
title_full_unstemmed Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial
title_short Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial
title_sort aerobic exercise in hiv-associated neurocognitive disorders: protocol for a randomized controlled trial
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844984/
https://www.ncbi.nlm.nih.gov/pubmed/35099405
http://dx.doi.org/10.2196/29230
work_keys_str_mv AT nwekemartins aerobicexerciseinhivassociatedneurocognitivedisordersprotocolforarandomizedcontrolledtrial
AT mshunqanenombeko aerobicexerciseinhivassociatedneurocognitivedisordersprotocolforarandomizedcontrolledtrial
AT govendernalini aerobicexerciseinhivassociatedneurocognitivedisordersprotocolforarandomizedcontrolledtrial
AT akinpeluaderonke aerobicexerciseinhivassociatedneurocognitivedisordersprotocolforarandomizedcontrolledtrial
AT ogunniyiadesola aerobicexerciseinhivassociatedneurocognitivedisordersprotocolforarandomizedcontrolledtrial